Expanded Label Officially Makes Bempedoic Acid a CVD Prevention Medication
(MedPage Today) -- The FDA approved label expansions for bempedoic acid (Nexletol) and bempedoic acid/ezetimibe (Nexlizet) so they can be used more broadly as cardiovascular prevention drugs, Esperion announced Friday.
Based on the CLEAR Outcomes...
Source: MedPage Today Public Health - Category: American Health Source Type: news
More News: American Health | Cardiology | Cardiovascular | Heart | International Medicine & Public Health | Vytorin | Zetia